Focal adhesion kinase as well as p130Cas and paxillin is crucially involved in the enhanced malignant properties under expression of ganglioside GD3 in melanoma cells.
Mass spectrometry analysis of immunoprecipitates from serum-treated GD3-expressing melanoma cells with PY20 (anti-phosphotyrosine antibody) revealed that focal adhesion kinase (FAK) is more strongly activated in GD3-expressing cells than in GD3-negative cells. Involvement of FAK in the increased proliferation and invasion in GD3-expressing melanomas was demonstrated by siRNA-mediated knockdown. Also, it was shown that FAK is located up-stream of p130Cas and paxillin in the enhanced signaling pathway. GD3 expression enhanced the association of FAK with p130Cas after treatment with fetal calf serum. Thus, focal adhesion kinase as well as p130Cas and paxillin should be a crucial molecule undergoing stronger tyrosine phosphorylation in GD3-expressing melanoma cells. Molecules linking GD3 and FAK such as integrins in the enhanced signaling pathway remain to be investigated.
Hamamura
Kazunori
K
Department of Biochemistry II, Nagoya University Graduate School of Medicine, 65 Tsurumai, Showa-ku, Nagoya 466-0065, Japan.
Tsuji
Momoko
M
Ohkawa
Yuki
Y
Nakashima
Hideyuki
H
Miyazaki
Sayaka
S
Urano
Takeshi
T
Yamamoto
Noriyuki
N
Ueda
Minoru
M
Furukawa
Koichi
K
Furukawa
Keiko
K
D000595:Amino Acid Sequence; D000818:Animals; D000911:Antibodies, Monoclonal / Q000494:pharmacology; D002417:Cattle; D045744:Cell Line, Tumor; D049109:Cell Proliferation / Q000187:drug effects; D050719:Crk-Associated Substrate Protein / Q000378:metabolism*; D051416:Focal Adhesion Protein-Tyrosine Kinases / Q000737:chemistry / Q000378:metabolism*; D005732:Gangliosides / Q000378:metabolism*; D006801:Humans; D047468:Immunoprecipitation; D013058:Mass Spectrometry; D008545:Melanoma / Q000201:enzymology* / Q000473:pathology*; D008969:Molecular Sequence Data; D009154:Mutation / Q000235:genetics; D009361:Neoplasm Invasiveness; D051419:Paxillin / Q000378:metabolism*; D010766:Phosphorylation / Q000187:drug effects; D019000:Phosphotyrosine / Q000378:metabolism; D011485:Protein Binding / Q000187:drug effects; D044967:Serum; D014162:Transfection
D000911:Antibodies, Monoclonal; C493841:BCAR1 protein, human; D050719:Crk-Associated Substrate Protein; D005732:Gangliosides; D051419:Paxillin; D019000:Phosphotyrosine; C026226:ganglioside, GD3; D051416:Focal Adhesion Protein-Tyrosine Kinases